Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease

Dry eye disease (DED) is a multifactorial disease of ocular surface and tear film, and is a common disorder treated by eye care providers. It is well established that ocular surface inflammation has an important role in the pathophysiology of DED and that anti-inflammatory cyclosporine A (CsA) impro...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Rodrigo Carlos, Wilson, Steven E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612764/
https://www.ncbi.nlm.nih.gov/pubmed/31308620
http://dx.doi.org/10.2147/OPTH.S184412
_version_ 1783432932899160064
author de Oliveira, Rodrigo Carlos
Wilson, Steven E
author_facet de Oliveira, Rodrigo Carlos
Wilson, Steven E
author_sort de Oliveira, Rodrigo Carlos
collection PubMed
description Dry eye disease (DED) is a multifactorial disease of ocular surface and tear film, and is a common disorder treated by eye care providers. It is well established that ocular surface inflammation has an important role in the pathophysiology of DED and that anti-inflammatory cyclosporine A (CsA) improves the treatment outcomes of most patients with DED. The purpose of this review is to provide guidance for practitioners in the use of topical CsA for the management of DED to improve patient satisfaction and the quality of life.
format Online
Article
Text
id pubmed-6612764
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66127642019-07-15 Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease de Oliveira, Rodrigo Carlos Wilson, Steven E Clin Ophthalmol Review Dry eye disease (DED) is a multifactorial disease of ocular surface and tear film, and is a common disorder treated by eye care providers. It is well established that ocular surface inflammation has an important role in the pathophysiology of DED and that anti-inflammatory cyclosporine A (CsA) improves the treatment outcomes of most patients with DED. The purpose of this review is to provide guidance for practitioners in the use of topical CsA for the management of DED to improve patient satisfaction and the quality of life. Dove 2019-07-01 /pmc/articles/PMC6612764/ /pubmed/31308620 http://dx.doi.org/10.2147/OPTH.S184412 Text en © 2019 de Oliveira and Wilson. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
de Oliveira, Rodrigo Carlos
Wilson, Steven E
Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
title Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
title_full Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
title_fullStr Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
title_full_unstemmed Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
title_short Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
title_sort practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612764/
https://www.ncbi.nlm.nih.gov/pubmed/31308620
http://dx.doi.org/10.2147/OPTH.S184412
work_keys_str_mv AT deoliveirarodrigocarlos practicalguidancefortheuseofcyclosporineophthalmicsolutionsinthemanagementofdryeyedisease
AT wilsonstevene practicalguidancefortheuseofcyclosporineophthalmicsolutionsinthemanagementofdryeyedisease

Ejemplares similares